Solid renal masses: What the numbers tell us

American Journal of Roentgenology

Volumn 202, Issue 6, 2014, Pages 1196-1206

  Kang, Stella K ^a   Huang, William C ^b   Pandharipande, Pari V ^c   Chandarana, Hersh ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Angiomyolipoma; Diffusion weighted imaging; Oncocytoma; Renal cell carcinoma; Renal mass

Indexed keywords

ALGORITHM; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; EVIDENCE BASED PRACTICE; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGING SYSTEM; KIDNEY CARCINOMA; KIDNEY TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME; DIAGNOSTIC ERROR; EVIDENCE BASED MEDICINE; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

DIAGNOSTIC ERRORS; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84904133847     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.14.12502     Document Type: Review

References (92)

1. Gill IS, Aron M, Gervais DA, Jewett MA. Clinical practice: small renal mass. N Engl J Med 2010; 362:624-634
2. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998; 51:203-205 (Pubitemid 28093168)
3. American Joint Committee on Cancer. Kidney. In: Edge SB, Byrd DR, Compton CC, et al., eds. AJCC cancer staging manual. 7th ed. New York: Springer, 2010:479-489
4. Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol 2009; 182:1271-1279
5. Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006; 7:735-740 (Pubitemid 44283660)
6. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006; 98:1331-1334 (Pubitemid 44530728)
7. Rothman J, Egleston B, Wong YN, Iffrig K, Lebovitch S, Uzzo RG. Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis. J Urol 2009; 181:29-33; discussion, 33-34
8. Thompson RH, Kurta JM, Kaag M, et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol 2009; 181:2033-2036
9. Jamis-Dow CA, Choyke PL, Jennings SB, Linehan WM, Thakore KN, Walther MM. Small (< or = 3-cm) renal masses: detection with CT versus US and pathologic correlation. Radiology 1996; 198:785-788
10. Hoffmann U, Edwards JM, Carter S, et al. Role of duplex scanning for the detection of atherosclerotic renal artery disease. Kidney Int 1991; 39:1232-1239
11. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006; 175:425-431 (Pubitemid 43067318)
12. Kunkle DA, Crispen PL, Chen DY, Greenberg RE, Uzzo RG. Enhancing renal masses with zero net growth during active surveillance. J Urol 2007; 177:849-853; discussion, 853-844
13. Pahernik S, Ziegler S, Roos F, Melchior SW, Thuroff JW. Small renal tumors: correlation of clinical and pathological features with tumor size. J Urol 2007; 178:414-417; discussion, 416-417
14. Reuter VE. The pathology of renal epithelial neoplasms. Semin Oncol 2006; 33:534-543 (Pubitemid 44511979)
15. Patard JJ, Leray E, Rioux-Leclercq N, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 2005; 23:2763-2771 (Pubitemid 46179466)
16. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003; 27:612-624 (Pubitemid 36514472)
17. Pignot G, Elie C, Conquy S, et al. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology 2007; 69:230-235 (Pubitemid 46274917)
18. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003; 170:2217-2220 (Pubitemid 37413960)
19. Smaldone MC, Kutikov A, Egleston BL, et al. Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 2012; 118:997-1006
20. Thompson RH, Hill JR, Babayev Y, et al. Metastatic renal cell carcinoma risk according to tumor size. J Urol 2009; 182:41-45
21. Klatte T, Patard JJ, de Martino M, et al. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol 2008; 179:1719-1726
22. Nguyen MM, Gill IS. Effect of renal cancer size on the prevalence of metastasis at diagnosis and mortality. J Urol 2009; 181:1020-1027; discussion, 1027
23. Zhang J, Kang SK, Wang L, Touijer A, Hricak H. Distribution of renal tumor growth rates determined by using serial volumetric CT measurements. Radiology 2009; 250:137-144
24. American College of Radiology. ACR appropriateness criteria: indeterminate renal masses. American College of Radiology website. www.acr.org/~/media/ACR/Documents/Appcriteria/Diagnostic/ IndeterminateRenalMasses.pdf. Published 1996. Updated 2010. Accessed December 19, 2013
25. Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Raman SS. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 2013; 267:444-453
26. Zhang J, Lefkowitz RA, Ishill NM, et al. Solid renal cortical tumors: differentiation with CT. Radiology 2007; 244:494-504 (Pubitemid 47080882)
27. Kim JK, Kim TK, Ahn HJ, Kim CS, Kim KR, Cho KS. Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR 2002; 178:1499-1506 (Pubitemid 34547840)
28. Herts BR, Coll DM, Novick AC, et al. Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR 2002; 178:367-372 (Pubitemid 34098041)
29. Ruppert-Kohlmayr AJ, Uggowitzer M, Meissnitzer T, Ruppert G. Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters. AJR 2004; 183:1387-1391 (Pubitemid 44210606)
30. Smith-Bindman R. Is computed tomography safe? N Engl J Med 2010; 363:1-4
31. Smith-Bindman R, Lipson J, Marcus R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009; 169:2078-2086
32. Brenner DJ, Doll R, Goodhead DT, et al. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci USA 2003; 100:13761-13766 (Pubitemid 37499140)
33. Prakash P, Kalra MK, Kambadakone AK, et al. Reducing abdominal CT radiation dose with adaptive statistical iterative reconstruction technique. Invest Radiol 2010; 45:202-210
34. Graser A, Johnson TR, Hecht EM, et al. Dual-energy CT in patients suspected of having renal masses: can virtual nonenhanced images replace true nonenhanced images? Radiology 2009; 252:433-440
35. Surveillance, Epidemiology, and End Results Program. SEER cancer statistics review, 1975-2003. National Cancer Institute website. www.seer.cancer.gov/csr/1975-2003/. Published April 2006. Accessed September 25, 2013
36. Jinzaki M, Tanimoto A, Narimatsu Y, et al. Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology 1997; 205:497-502 (Pubitemid 27467332)
37. Simpfendorfer C, Herts BR, Motta-Ramirez GA, et al. Angiomyolipoma with minimal fat on MDCT: can counts of negative-attenuation pixels aid diagnosis? AJR 2009; 192:438-443
38. Simpson E, Patel U. Diagnosis of angiomyolipoma using computed tomography: region of interest ≤ -10 HU or 4 adjacent pixels ≤ -10 HU are recommended as the diagnostic thresholds. Clin Radiol 2006; 61:410-416
39. Kim JY, Kim JK, Kim N, Cho KS. CT histogram analysis: differentiation of angiomyolipoma without visible fat from renal cell carcinoma at CT imaging. Radiology 2008; 246:472-479
40. Catalano OA, Samir AE, Sahani DV, Hahn PF. Pixel distribution analysis: can it be used to distinguish clear cell carcinomas from angiomyolipomas with minimal fat? Radiology 2008; 247:738-746
41. Chaudhry HS, Davenport MS, Nieman CM, Ho LM, Neville AM. Histogram analysis of small solid renal masses: differentiating minimal fat angiomyolipoma from renal cell carcinoma. AJR 2012; 198:377-383
42. Lesavre A, Correas JM, Merran S, Grenier N, Vieillefond A, Helenon O. CT of papillary renal cell carcinomas with cholesterol necrosis mimicking angiomyolipomas. AJR 2003; 181:143-145 (Pubitemid 36741475)
43. Richmond L, Atri M, Sherman C, Sharir S. Renal cell carcinoma containing macroscopic fat on CT mimics an angiomyolipoma due to bone metaplasia without macroscopic calcification. Br J Radiol 2010; 83:e179-e181
44. Prando A. Intratumoral fat in a renal cell carcinoma. AJR 1991; 156:871
45. Silverman SG, Israel GM, Herts BR, Richie JP. Management of the incidental renal mass. Radiology 2008; 249:16-31
46. Wile GE, Leyendecker JR, Krehbiel KA, Dyer RB, Zagoria RJ. CT and MR imaging after imaging-guided thermal ablation of renal neoplasms. RadioGraphics 2007; 27:325-339; discussion, 339-340
47. Bosniak MA. The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. Radiology 1991; 179:307-317
48. Jonisch AI, Rubinowitz AN, Mutalik PG, Israel GM. Can high-attenuation renal cysts be differentiated from renal cell carcinoma at unenhanced CT? Radiology 2007; 243:445-450 (Pubitemid 46649700)
49. Jinzaki M, Tanimoto A, Mukai M, et al. Doublephase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 2000; 24:835-842 (Pubitemid 32201804)
50. Fielding JR, Visweswaran A, Silverman SG, Granter SR, Renshaw AA. CT and ultrasound features of metanephric adenoma in adults with pathologic correlation. J Comput Assist Tomogr 1999; 23:441-444 (Pubitemid 29235159)
51. Hafron J, Fogarty JD, Hoenig DM, Li M, Berkenblit R, Ghavamian R. Imaging characteristics of minimal fat renal angiomyolipoma with histologic correlations. Urology 2005; 66:1155-1159 (Pubitemid 41797280)
52. Kim JK, Park SY, Shon JH, Cho KS. Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology 2004; 230:677-684 (Pubitemid 38252861)
53. Yang CW, Shen SH, Chang YH, et al. Are there useful CT features to differentiate renal cell carcinoma from lipid-poor renal angiomyolipoma? AJR 2013; 201:1017-1028
54. Birnbaum BA, Hindman N, Lee J, Babb JS. Renal cyst pseudoenhancement: influence of multidetector CT reconstruction algorithm and scanner type in phantom model. Radiology 2007; 244:767-775 (Pubitemid 47292087)
55. Tappouni R, Kissane J, Sarwani N, Lehman EB. Pseudoenhancement of renal cysts: influence of lesion size, lesion location, slice thickness, and number of MDCT detectors. AJR 2012; 198:133-137
56. Hecht EM, Israel GM, Krinsky GA, et al. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology 2004; 232:373-378 (Pubitemid 38971275)
57. Wildberger JE, Adam G, Boeckmann W, et al. Computed tomography characterization of renal cell tumors in correlation with histopathology. Invest Radiol 1997; 32:596-601 (Pubitemid 28069140)
58. Bird VG, Kanagarajah P, Morillo G, et al. Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography. World J Urol 2011; 29:787-792
59. Davidson AJ, Hayes WS, Hartman DS, McCarthy WF, Davis CJ Jr. Renal oncocytoma and carcinoma: failure of differentiation with CT. Radiology 1993; 186:693-696 (Pubitemid 23073509)
60. Kim JI, Cho JY, Moon KC, Lee HJ, Kim SH. Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma. Radiology 2009; 252:441-448
61. Woo S, Cho JY, Kim SH, Kim SY. Comparison of segmental enhancement inversion on biphasic MDCT between small renal oncocytomas and chromophobe renal cell carcinomas. AJR 2013; 201:598-604
62. McGahan JP, Lamba R, Fisher J, et al. Is segmental enhancement inversion on enhanced biphasic MDCT a reliable sign for the noninvasive diagnosis of renal oncocytomas? AJR 2011; 197:[web] W674-W679
63. O'Malley ME, Tran P, Hanbidge A, Rogalla P. Small renal oncocytomas: is segmental enhancement inversion a characteristic finding at biphasic MDCT? AJR 2012; 199:1312-1315
64. Choudhary S, Rajesh A, Mayer NJ, Mulcahy KA, Haroon A. Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin Radiol 2009; 64:517-522
65. Lane BR, Aydin H, Danforth TL, et al. Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol 2008; 180:836-843
66. Egbert ND, Caoili EM, Cohan RH, et al. Differentiation of papillary renal cell carcinoma subtypes on CT and MRI. AJR 2013; 201:347-355
67. Rosenkrantz AB, Hindman N, Fitzgerald EF, Niver BE, Melamed J, Babb JS. MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR 2010; 195:[web]W421-W427
68. Cornelis F, Lasserre AS, Tourdias T, et al. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas. AJR 2013; 200:830-838
69. Taouli B, Thakur RK, Mannelli L, et al. Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology 2009; 251:398-407
70. Bielsa O, Lloreta J, Gelabert-Mas A. Cystic renal cell carcinoma: pathological features, survival and implications for treatment. Br J Urol 1998; 82:16-20 (Pubitemid 28316664)
71. Han KR, Janzen NK, McWhorter VC, et al. Cystic renal cell carcinoma: biology and clinical behavior. Urol Oncol 2004; 22:410-414
72. Webster WS, Thompson RH, Cheville JC, Lohse CM, Blute ML, Leibovich BC. Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma. Urology 2007; 70:900-904; discussion, 904
73. Hindman N, Ngo L, Genega EM, et al. Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology 2012; 265:468-477
74. Oliva MR, Glickman JN, Zou KH, et al. Renal cell carcinoma: T1 and T2 signal intensity characteristics of papillary and clear cell types correlated with pathology. AJR 2009; 192:1524-1530
75. Israel GM, Hindman N, Hecht E, Krinsky G. The use of opposed-phase chemical shift MRI in the diagnosis of renal angiomyolipomas. AJR 2005; 184:1868-1872 (Pubitemid 40770162)
76. Chandarana H, Kang SK, Wong S, et al. Diffusion-weighted intravoxel incoherent motion imaging of renal tumors with histopathologic correlation. Invest Radiol 2012; 47:688-696
77. Kim S, Jain M, Harris AB, et al. T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging. Radiology 2009; 251:796-807
78. Zhang J, Tehrani YM, Wang L, Ishill NM, Schwartz LH, Hricak H. Renal masses: characterization with diffusion-weighted MR imaging - a preliminary experience. Radiology 2008; 247:458-464
79. Sandrasegaran K, Sundaram CP, Ramaswamy R, et al. Usefulness of diffusion-weighted imaging in the evaluation of renal masses. AJR 2010; 194:438-445
80. Wang H, Cheng L, Zhang X, et al. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T. Radiology 2010; 257:135-143
81. Cova M, Squillaci E, Stacul F, et al. Diffusion-weighted MRI in the evaluation of renal lesions: preliminary results. Br J Radiol 2004; 77:851-857 (Pubitemid 39504641)
82. Yu X, Lin M, Ouyang H, Zhou C, Zhang H. Application of ADC measurement in characterization of renal cell carcinomas with different pathological types and grades by 3.0T diffusion-weighted MRI. Eur J Radiol 2012; 81:3061-3066
83. Rosenkrantz AB, Niver BE, Fitzgerald EF, Babb JS, Chandarana H, Melamed J. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR 2010; 195:[web]W344-W351
84. Slywotzky C, Maya M. Needle tract seeding of transitional cell carcinoma following fine-needle aspiration of a renal mass. Abdom Imaging 1994; 19:174-176 (Pubitemid 24090572)
85. Campbell SC, Novick AC, Herts B, et al. Prospective evaluation of fine needle aspiration of small, solid renal masses: accuracy and morbidity. Urology 1997; 50:25-29 (Pubitemid 27300360)
86. Smith EH. Complications of percutaneous abdominal fine-needle biopsy. Radiology 1991; 178:253-258
87. Volpe A, Mattar K, Finelli A, et al. Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol 2008; 180:2333-2337
88. Wang R, Wolf JS, Jr, Wood DP, Jr, Higgins EJ, Hafez KS. Accuracy of percutaneous core biopsy in management of small renal masses. Urology 2009; 73:586-590; discussion, 590-591
89. DeLong W, Grignon DJ, Eberwein P, Shum DT, Wyatt JK. Sarcomatoid renal cell carcinoma: an immunohistochemical study of 18 cases. Arch Pathol Lab Med 1993; 117:636-640 (Pubitemid 23166785)
90. Rheinheimer S, Stieltjes B, Schneider F, et al. Investigation of renal lesions by diffusion-weighted magnetic resonance imaging applying intravoxel incoherent motion-derived parameters: initial experience. Eur J Radiol 2012; 81:e310-e316
91. Lanzman RS, Robson PM, Sun MR, et al. Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings. Radiology 2012; 265:799-808
92. Divgi CR, Uzzo RG, Gatsonis C, et al. Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial. J Clin Oncol 2013; 31:187-194